Abstract 495: Discovery of BPI-221351, a potent, selective, orally available, and brain penetrating dual inhibitor of mutant IDH1/2Hongling Shen, Jia‐Bing Wang, Yabin Li et al.|Cancer Research|2023Cited by 2